PARALLEL SESSION 2 // INFLAMMATORY MYOPATHIES

10:30 • S17L1 • Myositis classification for targeted treatments > O. Olivier BENVENISTE (Paris, France) 11:00 • S17L2 • Pathological features of myositis > I. Ichizo NISHINO (Kodaira, Japan) 11:30 • S17L3 • Absence of gene pathogenic variants and strong association with HLA-DRB1*11:01 in statin-naïve early-onset anti-HMG-CoA reductase necrotizing myopathy > L. Laura LLANSO CALDENTEY (Barcelona, Spain) 11:45 • S17L4 • Proteomic profiling to define IIM-associated marker proteins in cultured human myoblasts > A. Andreas ROOS (Dusseldorf, Germany)